Skip to main content

Table 3 Multivariate analysis for risk factors associated with urgent/emergent surgery

From: Rectal-sparing type of ulcerative colitis predicts lack of response to pharmacotherapies

Risk Factors

OR(95% CI)

p-value

Age at initial surgery <44 years

1.94(0.93-4.17)

0.08

Duration of disease(month) < 70 months

2.45(1.10-5.54)

0.03*

Severe/Fuluminant disease

87.1(40.9-205.1)

<0.01*

Total given PSL dose <5000 mg

3.02(1.39-6.76)

<0.01*

Daily pre-operative PSL dose ≥9 mg/day

2.59(1.20-5.65)

0.02*

Immunomodulators administration (AZA/6-MP)

0.68(0.26-1.69)

0.41

Rectal sparing type

5.59(1.90-16.9)

<0.01*

  1. OR = Odds Ratio; CI = Confidence Interval; PSL = Prednisolone; AZA = Azathioprine;6-MP = 6-Mercaptopurine
  2. *p < 0.05 (Significantly different)